InStar Technologies


InStar Technologies is a biopharmaceutical company specializing in innovative oromucosal drug delivery solutions through their patented InStrip Technology. They focus on developing products that address unmet therapeutic needs, utilizing high barrier technology, and providing comprehensive lifecycle management. Their mission is to revolutionize healthcare by enabling needle-free, efficient, and versatile delivery of peptides, proteins, vaccines, and other active substances via oral thin films, suitable for both human and veterinary use.

Industries

Biotechnology
Pharmaceutical Manufacturing

Nr. of Employees

small (1-50)

InStar Technologies


Patents

Oromucosal nanofiber carriers for therapeutic treatment

US-12194158-B2

View Details

Carrier for oromucosal administration of physiologically active substances

US-11771648-B2

View Details

Carrier for oromucosal administration of physiologically active substances

US-9789060-B2

View Details

Products

Oral thin film cannabidiol formulation (example product)

Oral thin film formulation delivering cannabidiol via oromucosal route, designed for rapid onset and dose reduction compared with traditional oral dosing.

Cebedix

An oral thin film utilizing InStrip technology with CBD (Cannabidiol) designed for fast mouth-soluble administration.

InStrip

An innovative oromucosal drug delivery technology developed by InStar Technologies for administering various drug substances ranging from nutraceuticals and small molecules to peptides, proteins, and vaccines.

InStrip OTF Technology

An innovative oral thin film technology providing extensive mucoadhesive properties, maximum transfer of active ingredients, and enhanced bioavailability for oromucosal administration.


Services

Contract manufacturing of oral thin films under GMP for pharmaceutical and veterinary use, including multi-layer nanofiber films and production at varying batch sizes.

Collaborative formulation and development of nutraceutical and pharmaceutical OTF products (small molecules, peptides, proteins), including feasibility studies and controlled-release design.

Coordination of preclinical and clinical studies and preparation of regulatory dossiers through cooperation with certified external laboratories and clinical sites.

Expertise Areas

  • Oromucosal drug delivery
  • Oral thin film (OTF) formulation
  • Peptide and protein formulation for non-invasive delivery
  • Mucosal vaccine delivery
  • Show More (5)

Key Technologies

  • Oral thin film (OTF) platforms
  • Nanofiber multilayer deposition
  • Mucoadhesive formulation technology
  • Pharmaceutical polymers for tunable release
  • Show More (4)

News & Updates

Meet us at World Vaccine Congress Europe held in Barcelona. Featuring Gyan Sagar as a speaker for topic 'Oromucosal vaccine delivery platform'.

Meet us at LSX WORLD CONGRESS USA held in Boston on June 21-21, 2022.

Meet us at BIO International Convention held in San Diego on June 13-16, 2022.

Meet us at LSX WORLD CONGRESS held in London on May 10-11, 2022.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.